Bioanalysis of recombinant proteins and antibodies by mass spectrometry

文献信息

发布日期 2009-03-24
DOI 10.1039/B819706G
影响因子 4.616
作者

Eric Ezan, Mathieu Dubois, François Becher



摘要

In recent years, biotechnologically-derived drugs have been a major focus of research and development in the pharmaceutical industry. Their pharmacokinetics and pharmacokinetic/pharmacodynamic relationships impact every stage of the development process and require their assessment in the circulation in preclinical species and in humans. To this end, immunoassays are a reference, but standardisation remains an issue owing to the restricted pattern of antibody specificity and interference with endogenous components. As an alternative, we report here analytical strategies involving liquid chromatography coupled to mass spectrometry (LC-MS) for the accurate quantification of therapeutic proteins and antibodies in biological fluids.

来源期刊

Analyst

Analyst
CiteScore: 7.8
自引率: 5.6%
年发文量: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

推荐供应商

中国淮北新兴实业有限责任公司
德国Sohena GmbH
中国DYMATIC化学公司
中国杭州杭氧小型空气压缩机有限公司
德国QUMA Elektronik & Analytik GmbH
德国Hochrein测量技术
印度尼西亚Van Aroma
CE光学
中国山东合晖国际贸易有限公司
中国安徽南方化工泵业有限公司
免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 [email protected] 联系我们。我们将及时核实并处理您的问题。